or
Bookmark and Share
COMPOSITION AND METHOD FOR LOWERING THE BLOOD SUGAR CONTENT OF DIABETIC MAMMALS
   
Document Number
US Patent 3671532
Issued Date
June 20, 1972
Link
Inventors
Carraz; Gilbert L. (St. Jean de Moirans,FR)
Map
Abstract
The invention relates to a method of lowering the blood sugar content in mammals by exploiting the hypoglycemic activity of certain pentacyclic triterpene derivatives such as mixtures of glycyrrhetinic acids and their esters, to treat obese diabetic subjects.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
3
Comments:
no comments yet
Published
June 20, 1972
Application Number
04/620,631
Filed
March 6, 1967
US Classification
514/549   514/557 514/866
Int'l Classification
A61K   31/00   (20060101)  
Examiner
Priority Data
Aug 05, 1966 [FR] 66838 Dec 29, 1966 [FR] 66844
USPTO Field of Search
260/514   167/65AD   424/317   424/305  
Related Patents
5314877 - Water-soluble pentacyclic triterpene composition and method for producing the same - Owned by Hokkaido Sugar Co., Ltd. (Tokyo,JP)

Disclosed is water-soluble composition made by subjecting pentacyclic triterpene compound belonging to amylin group such as oleanolic acid, ursolic acid and hederagenin to inclusion in cyclodextrins. Though the aforementioned pentacyclic triterpene compound has various pharmacological functions, it has suffered a disadvantage such that it is insoluble in water. However, by subjecting the compound to inclusion in cyclodextrins, the water-soluble composition can be made with maintaining the pharmacological functions, and applied for foods, drinks, toothpaste, gargle and chewing gum, exhibiting the effect of cariostatic.

6326396 - Glucose and lipid lowering compounds - Owned by Alteon, Inc. (Ramsey, NJ)

Provided are, among other things, lipid-lowering or glucose-lowering methods and compounds, particularly lipid-lowering or glucose-lowering compounds, with an A-B ring structure as follows: ##STR1## wherein the dotted line between carbons 5 and 6, the dotted line between carbon 4 and R.sup.2, and the dotted line between carbon 11 and R.sup.3 each independently represent an optional double bond from the respective numbered carbon to a linked carbon, and wherein X is hydroxy or, together with Y is oxy linking carbon 8 and carbon 12.

6509480 - Glucose and lipid lowering compounds - Owned by Alteon, Inc. (Ramsey, NJ)

Provided are, among other things, lipid-lowering or glucose-lowering methods and compounds, particularly lipid-lowering or glucose-lowering compounds, with an A-B ring structure as follows: ##STR1## wherein the dotted line between carbons 5 and 6, the dotted line between carbon 4 and R.sup.2, and the dotted line between carbon 11 and R.sup.3 each independently represent an optional double bond from the respective numbered carbon to a linked carbon, and wherein X is hydroxy or, together with Y is oxy linking carbon 8 and carbon 12.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us